C&R Research
- Company typePrivate
- Founded1997
- HeadquartersYeoksamdong, South Korea
- Headcount51–100
- GTM typeB2B
- OfferingServices
C&R Research firmographics
Firmographics- Name
- C&R Research
- Legal name
- C&R Research Co., Ltd.
- Website
- https://cnrres.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
C&R Research industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)
Keywords
Where C&R Research is headquartered
LocationHeadquarters
- HQ city
- Yeoksamdong
- HQ country
- South Korea
- HQ region
- Asia
Offices6 records
Markets served
C&R Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- CRO Contract Research Services: Full-service Contract Research Organization providing end-to-end clinical trial services including Phase 1-4 clinical trials, NIS/OS, PMS, and medical device studies. Revenue generated through project-based contracts with pharmaceutical, biotech, and medical device companies.
- Specialized Clinical Consulting: Medical advisory, regulatory consulting, pharmacometric analysis, and training services through C&R Academy, which is an MFDS-designated clinical trial education institution.
Go-to-market motion3 records
Distribution channels2 records
Marketing channels4 records
C&R Research product offering
Product offeringCore offering
C&R Research is Korea's first independent Contract Research Organization (CRO), founded in 1997, providing end-to-end clinical trial services for pharmaceutical, biotechnology, and medical device companies. Services span Phase 1-4 clinical trials, real-world studies, post-marketing surveillance, regulatory affairs, data management, biostatistics, pharmacovigilance, quality management, and medical device trials. The company has conducted 1,800+ trials with 500+ clinical experts and operates its proprietary imtrial clinical process automation platform.
Product overview
C&R Research (씨엔알리서치) is Korea's first independent CRO, established in 1997 with over 500 employees. The company provides end-to-end clinical trial services across the full drug development lifecycle from first-in-human through NDA approval. Its core product is Full Service CRO offerings including Medical Advisory & Consulting, Early-Phase Clinical Development, Trial Management (Phase 1-3 and Real-World), Regulatory Affairs, Data Management, Biostatistics, Pharmacovigilance, and Quality Management. Key proprietary platforms include imtrial, a clinical process automation platform providing MDR and TDLM services with standard API access, and C&R Academy, a MFDS-designated clinical education institution. Subsidiaries include Trial Informatics (US-based EDC platform), TI Image (clinical imaging CRO), Mediplexus (RWD/RWE data specialist), and C&R Healthcare Global (ASEAN regional HQ). Services span oncology, rare diseases, cardiovascular, endocrinology, dermatology, ophthalmology, CNS, and cover biotechnology (biosimilars, CAR-T, cell/gene therapy, ADC), pharmaceuticals (novel drugs, improved drugs, generics), and medical devices sectors. The company holds KoNECT Innovative CRO certification (2023) and operates globally with offices in the US, Singapore, Thailand, and Indonesia.
Differentiator
Problem solved
Functional benefit
Brands
- imtrial: Clinical process automation platform developed by C&R Research, providing MDR (Metadata Repository) and TDLM (Trial Data Lifecycle Management) services for clinical trial data management, eCRF auto-generation, and SDTM Package automation.
- C&R Academy
Products and services
- Full Service CRO End-to-end clinical trial services from researcher selection through NDA approval, covering clinical trial planning, IND applications, trial operations, data management, statistical analysis, and result reporting for pharmaceutical, biotech, and medical device companies.
- imtrial Platform Clinical process automation platform providing MDR (Metadata Repository) and TDLM (Trial Data Lifecycle Management) services for standardized data storage, eCRF auto-generation, and SDTM Package automation. Includes standard API access for integration with clinical research platforms and CROs.
- C&R Academy
Companies that use C&R Research
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
C&R Research technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature4 records
C&R Research partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- AIMneXtcoreC&R Research contracted to conduct US pivotal clinical trial for AIMneXt's digital therapeutic Somzz (Korea's first approved DTx for insomnia). C&R's medical device team and US subsidiary Trial Informatics collaborating to support AIMneXt's FDA approval process.
- VietStar Biomedical ResearchminorStrategic agreement with Vietnam CRO company VietStar Biomedical Research to build multi-country clinical operational system in Southeast Asia and strengthen local clinical execution capabilities.
- Smart ResearchminorStrategic agreement with Vietnam CRO company Smart Research to build multi-country clinical operational system in Southeast Asia and strengthen local clinical execution capabilities.
- Taimei TechnologycoreStrategic partnership to develop AI-based clinical trial operations system. C&R Research deploying Taimei Technology's digital infrastructure and AI Agents including EDC + iDM Agent combination across multiple clinical trials. Focus on automating trial design and operational workflows, including AI-driven eCRF generation and automated test case creation. C&R secured 1-year exclusive rights for Taimei AI Agent in Korea.
- KoNECT (Korea National Enterprise for Clinical Trials)coreBusiness agreement with KoNECT for global clinical trial expansion cooperation. C&R supporting domestic companies' overseas advancement based on global clinical experience and network, while strengthening domestic clinical trial ecosystem competitiveness.
- KIMCo (Korea Innovative Medicines Consortium)minorMOU signed in 2024 with Thailand subsidiary to strengthen Korea-Thailand clinical cooperation and expand regional frameworks supporting Korean pharmaceutical companies' entry into ASEAN markets.
- Trial Informatics (트라이얼인포매틱스)coreUS subsidiary providing proprietary EDC platform for clinical trial data management. Collaborates with C&R medical device team for US clinical trial operations and FDA approval support.
- C&R Healthcare Global (씨엔알헬스케어글로벌)coreASEAN clinical overseas subsidiary handling regional clinical operations and business development across Southeast Asia markets.
- C&R SMO (씨엔알에스엠오)minorClinical trial site management organization supporting trial execution and site coordination.
- ABC BioscienceminorFull-cycle drug development consulting company integrated into C&R network for comprehensive service offering.
Scale indicators9 records
Recent moves12 records
Expansion highlights7 records
C&R Research competitors and assessment
Company assessmentBroad incumbents
- ICON plc: Global CRO providing full-service Phase 1-4 trial management, bioanalytical, and consulting services. Competes for the same Korean and Asian pharma outsourcing contracts as C&R, particularly in multi-region trials.
- Fortrea (formerly LabCorp Drug Development / Covance): Large global CRO spun out from LabCorp offering clinical trial management, central laboratory, and consulting services. Targets similar Korean and Asian pharma clients seeking FDA-compliant clinical development.
- Parexel: Global CRO with deep regulatory expertise and FDA submission track record. Direct competitor for Korean pharma seeking US FDA pathway support, an area where C&R is building capability via its Boston subsidiary.
- IQVIA: World's largest CRO with comprehensive clinical, technology, and consulting services across all phases. Direct competitor for Korean pharma seeking global clinical trials; C&R's VP previously served as IQVIA Korea country manager, illustrating talent flow between the two.
- Charles River Laboratories: Global CRO with strong preclinical-to-clinical continuum, particularly in oncology and rare disease. Competes for the same Korean biotech and pharma clients requiring integrated early-stage development.
- WuXi AppTec: China-headquartered global CRO/CDMO providing comprehensive drug development services including clinical trials. Asian regional competitor with overlapping therapeutic area expertise and global ambitions.
Direct peers
- Medpace: Mid-sized US-headquartered full-service CRO focused on small-to-mid biotech and pharma sponsors. Comparable in scale and operating model to C&R's full-service offering, though focused primarily on Western markets.
- Tigermed: China's largest CRO offering full-service clinical trial management, biostatistics, and regulatory services. Regional peer in Asian CRO market with comparable service breadth and growing international footprint.
- LSK Global Pharma Services: Korea-headquartered CRO providing clinical trial management and biostatistics services. Most direct domestic competitor to C&R Research in Korean pharma CRO market, with overlapping client base and service offerings.
- Novotech: Asia-Pacific-focused CRO providing full-service clinical trial services across the region, particularly Australia and Southeast Asia. Closest direct competitor for Asian multi-country trials and overlapping with C&R's ASEAN expansion strategy.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
C&R Research compliance and trust
Trust signalCompliance1 record
C&R Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
C&R Research leadership team
Management profileNumber of profiles
Profiles4 records
C&R Research subsidiaries and ownership
Company hierarchySubsidiaries6 records
C&R Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
C&R Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about C&R Research
What does C&R Research do?
C&R Research is Korea's first independent Contract Research Organization (CRO), founded in 1997, providing end-to-end clinical trial services for pharmaceutical, biotechnology, and medical device companies. Services span Phase 1-4 clinical trials, real-world studies, post-marketing surveillance, regulatory affairs, data management, biostatistics, pharmacovigilance, quality management, and medical device trials. The company has conducted 1,800+ trials with 500+ clinical experts and operates its proprietary imtrial clinical process automation platform.
Is C&R Research a public or private company?
C&R Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was C&R Research founded?
C&R Research was founded in 1997. It employs 51 to 100 people.
Where is C&R Research based?
C&R Research is headquartered in Yeoksamdong, South Korea, in the Asia region.
How does C&R Research make money?
Two revenue lines are on record. CRO Contract Research Services are the primary driver. The others are specialized Clinical Consulting.
Who are C&R Research's main competitors?
Broad incumbents on record are ICON plc, Fortrea (formerly LabCorp Drug Development / Covance), Parexel, IQVIA, Charles River Laboratories and WuXi AppTec. Direct peers are Medpace, Tigermed, LSK Global Pharma Services and Novotech.
Does C&R Research have an API?
Yes. imtrial is a clinical process automation platform that provides standard API access, enabling direct connection with clinical research platforms, pharmaceutical companies, hospitals, and CROs for workflow integration and data exchange.
What industry is C&R Research in?
C&R Research's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.